![Jennifer Augusti](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jennifer Augusti
Direttore Finanziario/CFO presso Xylocor Therapeutics, Inc.
Posizioni attive di Jennifer Augusti
Società | Posizione | Inizio | Fine |
---|---|---|---|
Xylocor Therapeutics, Inc.
![]() Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Direttore operativo | - | - |
Direttore Finanziario/CFO | - | - |
Storia della carriera di Jennifer Augusti
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Posizioni
Chief Operating Officer | 1 |
Director of Finance/CFO | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Xylocor Therapeutics, Inc.
![]() Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Health Technology |
- Borsa valori
- Insiders
- Jennifer Augusti
- Esperienza